Junzhao Ye

997 total citations
49 papers, 589 citations indexed

About

Junzhao Ye is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Junzhao Ye has authored 49 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 26 papers in Hepatology and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Junzhao Ye's work include Liver Disease Diagnosis and Treatment (43 papers), Liver Disease and Transplantation (20 papers) and Diet, Metabolism, and Disease (17 papers). Junzhao Ye is often cited by papers focused on Liver Disease Diagnosis and Treatment (43 papers), Liver Disease and Transplantation (20 papers) and Diet, Metabolism, and Disease (17 papers). Junzhao Ye collaborates with scholars based in China, United States and Canada. Junzhao Ye's co-authors include Congxiang Shao, Bihui Zhong, Fuxi Li, Shi‐Ting Feng, Wei Wang, Yansong Lin, Bihui Zhong, Yanhong Sun, Yanqin Wu and Qianqian Ma and has published in prestigious journals such as American Journal of Clinical Nutrition, The Journal of Infectious Diseases and Nutrients.

In The Last Decade

Junzhao Ye

46 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junzhao Ye China 15 481 206 169 136 123 49 589
Eda Kaya Türkiye 14 488 1.0× 217 1.1× 232 1.4× 81 0.6× 64 0.5× 37 565
Kamran Qureshi United States 12 305 0.6× 129 0.6× 157 0.9× 88 0.6× 88 0.7× 46 529
Saeed Esmaili Australia 13 792 1.6× 234 1.1× 351 2.1× 158 1.2× 139 1.1× 19 963
Sam Trinh United States 7 629 1.3× 270 1.3× 279 1.7× 89 0.7× 65 0.5× 12 693
Nicholas Chien United States 6 591 1.2× 283 1.4× 232 1.4× 96 0.7× 65 0.5× 11 678
Michihiro Iwaki Japan 13 399 0.8× 118 0.6× 196 1.2× 79 0.6× 100 0.8× 44 540
Yunhao Xun China 13 440 0.9× 117 0.6× 211 1.2× 47 0.3× 83 0.7× 42 566
Johannie du Plessis Belgium 7 416 0.9× 121 0.6× 188 1.1× 108 0.8× 96 0.8× 8 545
Sanja Stojsavljević Croatia 9 357 0.7× 127 0.6× 139 0.8× 68 0.5× 88 0.7× 16 477
Nadege Gunn United States 10 439 0.9× 188 0.9× 210 1.2× 52 0.4× 159 1.3× 21 583

Countries citing papers authored by Junzhao Ye

Since Specialization
Citations

This map shows the geographic impact of Junzhao Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junzhao Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junzhao Ye more than expected).

Fields of papers citing papers by Junzhao Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junzhao Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junzhao Ye. The network helps show where Junzhao Ye may publish in the future.

Co-authorship network of co-authors of Junzhao Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Junzhao Ye. A scholar is included among the top collaborators of Junzhao Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junzhao Ye. Junzhao Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Junzhao, Jiaming Lai, Xiaodong Zhuang, et al.. (2025). Machine Learning Models for Screening Steatosis in MASLD : An International Validation Study. Liver International. 45(12). e70416–e70416.
2.
Ye, Junzhao, et al.. (2025). Cytokeratin 18 fragment in liver inflammation and fibrosis: Systematic review and meta-analysis. Clinica Chimica Acta. 569. 120147–120147. 1 indexed citations
3.
Ye, Junzhao, Ting Zhou, Zhi Dong, et al.. (2025). Weight-loss plateau during lifestyle intervention predicts treatment response in patients with MASLD and obesity. Obesity Facts. 18(4). 1–21. 1 indexed citations
4.
Wang, Hao, Junzhao Ye, Youpeng Chen, et al.. (2025). High sensitivity C-reactive protein implicates heterogeneous metabolic phenotypes and severity in metabolic dysfunction associated-steatotic liver disease. BMC Gastroenterology. 25(1). 231–231. 1 indexed citations
5.
6.
Shao, Congxiang, Junzhao Ye, Zhi Dong, et al.. (2024). Phospholipid metabolism-related genotypes of PLA2R1 and CERS4 contribute to nonobese MASLD. Hepatology Communications. 8(6).
7.
Long, Teng, Yanhong Sun, Wei Wang, et al.. (2024). Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression. Nutrients. 17(1). 152–152. 2 indexed citations
8.
Ye, Junzhao, Sui-Lin Mo, Xiaoyi Li, et al.. (2024). Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians. Journal of Gastroenterology and Hepatology. 39(8). 1636–1647. 5 indexed citations
9.
Luo, Ling, Junzhao Ye, Shuyu Zhuo, et al.. (2024). Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment. HepatoBiliary Surgery and Nutrition. 13(4). 632–649. 2 indexed citations
10.
Shao, Congxiang, et al.. (2023). Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease. Journal of Translational Medicine. 21(1). 12–12. 11 indexed citations
11.
Lin, Yansong, Shuyu Zhuo, Zhi Dong, et al.. (2023). Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: A randomized controlled trial. American Journal of Clinical Nutrition. 117(4). 691–700. 15 indexed citations
12.
Shao, Congxiang, Junzhao Ye, Yansong Lin, et al.. (2022). Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations
13.
Ye, Junzhao, Congxiang Shao, Yansong Lin, et al.. (2022). Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection. Nutrients. 14(10). 2114–2114. 4 indexed citations
14.
Ma, Qianqian, Congxiang Shao, Yansong Lin, et al.. (2022). Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study. Diabetes Metabolic Syndrome and Obesity. Volume 15. 1173–1184. 7 indexed citations
15.
Ye, Junzhao, Xiaorong Gong, Xin Li, et al.. (2021). Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease. Digestive and Liver Disease. 53(12). 1610–1619. 6 indexed citations
16.
Ma, Qianqian, Congxiang Shao, Yansong Lin, et al.. (2021). Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease. BMC Gastroenterology. 21(1). 215–215. 12 indexed citations
17.
Lin, Yansong, Xiaorong Gong, Xin Li, et al.. (2021). Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China. Frontiers in Medicine. 7. 584396–584396. 20 indexed citations
18.
Ye, Junzhao, Congxiang Shao, Fuxi Li, et al.. (2021). Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease. Frontiers in Endocrinology. 12. 691556–691556. 12 indexed citations
19.
Ye, Junzhao, Yang Huang, Yanhong Sun, et al.. (2021). Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis. Annals of Translational Medicine. 9(21). 1613–1613. 5 indexed citations
20.
Shao, Congxiang, Junzhao Ye, Fuxi Li, et al.. (2019). Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. Digestive and Liver Disease. 51(10). 1392–1399. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eda Kaya Breakdown of academic impact, for papers by Kamran Qureshi Breakdown of academic impact, for papers by Saeed Esmaili Breakdown of academic impact, for papers by Sam Trinh Breakdown of academic impact, for papers by Nicholas Chien Breakdown of academic impact, for papers by Michihiro Iwaki Breakdown of academic impact, for papers by Yunhao Xun Breakdown of academic impact, for papers by Johannie du Plessis Breakdown of academic impact, for papers by Sanja Stojsavljević Breakdown of academic impact, for papers by Nadege Gunn
Rankless by CCL
2026